Low dose of targeted drug --- cancer-killing virus therapy

cp418

http://www.sciencedaily.com/releases/2014/06/140616204544.htm

Low dose of targeted drug might improve cancer-killing virus therapy
Giving low doses of the targeted agent bortezomib with a cancer-killing virus might improve the effectiveness of the virus as a treatment for cancer with little added toxicity. The findings support the testing of this combination therapy in a clinical trial.

cp418

http://www.sciencedaily.com/releases/2014/06/140611143653.htm

New tumor-targeting agent images, treats wide variety of cancers

A new class of tumor-targeting agents can seek out and find dozens of solid tumors, even illuminating brain cancer stem cells that resist current treatments, researchers report. What's more, years of animal studies and early human clinical trials show that this tumor-targeting, alkylphosphocholine (APC) molecule can deliver two types of "payloads" directly to cancer cells: a radioactive or fluorescent imaging label, or a radioactive medicine that binds and kills cancer cells.